Systematic review with meta‐analysis: coffee consumption and the risk of gallstone disease. Issue 6 (22nd July 2015)
- Record Type:
- Journal Article
- Title:
- Systematic review with meta‐analysis: coffee consumption and the risk of gallstone disease. Issue 6 (22nd July 2015)
- Main Title:
- Systematic review with meta‐analysis: coffee consumption and the risk of gallstone disease
- Authors:
- Zhang, Y.‐P.
Li, W.‐Q.
Sun, Y.‐L.
Zhu, R.‐T.
Wang, W.‐J. - Abstract:
- <abstract abstract-type="main" id="apt13328-abs-0001"> <title>Summary</title> <sec id="apt13328-sec-0001" sec-type="section"> <title>Background</title> <p>Epidemiologic evidence on coffee consumption reducing the risk of gallstone disease has been contradictory.</p> </sec> <sec id="apt13328-sec-0002" sec-type="section"> <title>Aim</title> <p>To perform a meta‐analysis of observational studies, to investigate an association and dose–response of coffee consumption with gallstone disease.</p> </sec> <sec id="apt13328-sec-0003" sec-type="section"> <title>Methods</title> <p>We used PubMed and EMBASE databases to identify all published studies before June 2015. A random‐effects model was used to compute a pooled relative risk (RR) and corresponding 95% confidence intervals (CIs).</p> </sec> <sec id="apt13328-sec-0004" sec-type="section"> <title>Results</title> <p>One case–control study and five prospective cohort studies (with seven cohorts) involving 227 749 participants and 11 477 gallstone disease cases were included. Coffee consumption was significantly associated with a reduced risk of gallstone disease (RR, 0.83; 95% CI, 0.76 to 0.89; <italic>I</italic><sup>2</sup> = 35.9%), based on prospective studies; specifically, we observed an inverse relation in females, but not in males. The case–control study did not reveal any association between coffee and gallstone disease (OR, 0.99; 95% CI, 0.64 to 1.53). In a dose–response analysis, the RR of gallstone disease was 0.95 (95% CI,<abstract abstract-type="main" id="apt13328-abs-0001"> <title>Summary</title> <sec id="apt13328-sec-0001" sec-type="section"> <title>Background</title> <p>Epidemiologic evidence on coffee consumption reducing the risk of gallstone disease has been contradictory.</p> </sec> <sec id="apt13328-sec-0002" sec-type="section"> <title>Aim</title> <p>To perform a meta‐analysis of observational studies, to investigate an association and dose–response of coffee consumption with gallstone disease.</p> </sec> <sec id="apt13328-sec-0003" sec-type="section"> <title>Methods</title> <p>We used PubMed and EMBASE databases to identify all published studies before June 2015. A random‐effects model was used to compute a pooled relative risk (RR) and corresponding 95% confidence intervals (CIs).</p> </sec> <sec id="apt13328-sec-0004" sec-type="section"> <title>Results</title> <p>One case–control study and five prospective cohort studies (with seven cohorts) involving 227 749 participants and 11 477 gallstone disease cases were included. Coffee consumption was significantly associated with a reduced risk of gallstone disease (RR, 0.83; 95% CI, 0.76 to 0.89; <italic>I</italic><sup>2</sup> = 35.9%), based on prospective studies; specifically, we observed an inverse relation in females, but not in males. The case–control study did not reveal any association between coffee and gallstone disease (OR, 0.99; 95% CI, 0.64 to 1.53). In a dose–response analysis, the RR of gallstone disease was 0.95 (95% CI, 0.91 to 1.00; <italic>P </italic>=<italic> </italic>0.049) per 1 cup/day of coffee consumption. A significant nonlinear dose–response association was also identified (<italic>P</italic> for nonlinearity = 0.0106). For people who drank 2, 4 and 6 cups of coffee per day, the estimated RRs of gallstone disease were 0.89 (95% CI, 0.79 to 0.99), 0.81 (95% CI, 0.72 to 0.92) and 0.75 (95% CI, 0.64 to 0.88), respectively, compared with the lowest level drinkers.</p> </sec> <sec id="apt13328-sec-0005" sec-type="section"> <title>Conclusion</title> <p>This study suggests that coffee consumption is related to a significantly decreased risk of gallstone disease.</p> </sec> </abstract> … (more)
- Is Part Of:
- Alimentary pharmacology & therapeutics. Volume 42:Issue 6(2015)
- Journal:
- Alimentary pharmacology & therapeutics
- Issue:
- Volume 42:Issue 6(2015)
- Issue Display:
- Volume 42, Issue 6 (2015)
- Year:
- 2015
- Volume:
- 42
- Issue:
- 6
- Issue Sort Value:
- 2015-0042-0006-0000
- Page Start:
- 637
- Page End:
- 648
- Publication Date:
- 2015-07-22
- Subjects:
- Digestive organs -- Diseases -- Treatment -- Periodicals
Digestive organs -- Effect of drugs on -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Effect of drugs on -- Periodicals
615.73 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/apt.13328 ↗
- Languages:
- English
- ISSNs:
- 0269-2813
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0787.886000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3252.xml